Compound 3l not only demonstrated strong anti-proliferation activities against the two cancer cell lines, but also showed significant inhibitory activity (LC50 = 37.66 nM) towards EGFR, comparable to that of the medicinally important EGFR inhibitor Gefitinib (LC50 = 31.44 nM). Here, EGFR is linked to cancer.